SteelPeak Wealth LLC Grows Position in Intuitive Surgical, Inc. $ISRG

SteelPeak Wealth LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 32,629 shares of the medical equipment provider’s stock after acquiring an additional 2,286 shares during the quarter. SteelPeak Wealth LLC’s holdings in Intuitive Surgical were worth $17,731,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of ISRG. Chilton Capital Management LLC lifted its position in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Elite Financial Inc. bought a new stake in shares of Intuitive Surgical during the 1st quarter worth $26,000. LFA Lugano Financial Advisors SA bought a new stake in shares of Intuitive Surgical during the 1st quarter worth $30,000. TD Capital Management LLC grew its position in Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares in the last quarter. Finally, 1248 Management LLC bought a new position in Intuitive Surgical in the first quarter valued at $30,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $449.69 on Tuesday. The company has a market capitalization of $161.20 billion, a P/E ratio of 62.72, a PEG ratio of 4.74 and a beta of 1.61. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The stock has a 50 day moving average price of $462.67 and a two-hundred day moving average price of $499.82.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. During the same quarter last year, the business earned $1.78 earnings per share. The business’s revenue was up 21.4% on a year-over-year basis. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the business’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the transaction, the director owned 739 shares in the company, valued at approximately $325,669.91. The trade was a 31.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock valued at $21,716,492 in the last quarter. Insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

Several brokerages have issued reports on ISRG. BTIG Research reaffirmed a “buy” rating and set a $571.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 1st. Wells Fargo & Company boosted their target price on Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Evercore ISI lifted their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 8th. Finally, Truist Financial boosted their price objective on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 23rd. Fourteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $594.19.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.